MDWD insider trading

NasdaqGM Healthcare

MediWound Ltd. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
6
Last 90 days
6
Buys / sells
100% / 0%
Market cap
$184.17M

About MediWound Ltd.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Company website: www.mediwound.com

MDWD insider activity at a glance

FilingIQ has scored 6 insider transactions for MDWD since May 29, 2026. The most recent filing in our index is dated Jun 3, 2026.

Across the full history, 6 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MDWD insider trades is 47.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for MDWD?
FilingIQ tracks 6 Form 4 insider transactions for MDWD (MediWound Ltd.), covering filings from May 29, 2026 onwards. 6 of those were filed in the last 90 days.
Are MDWD insiders net buyers or net sellers?
Across the full Form 4 history for MDWD, 6 transactions (100%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MDWD insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MDWD in?
MediWound Ltd. (MDWD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $184.17M.

Methodology & sources

Every MDWD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.